This translates to approximately 70+ pounds for someone starting at 250 pounds
Understanding these patterns helps individuals assess their own likely outcomes
December 15, 2022: Tirzepatide injection products (Mounjaro and Zepbound) were added to the drug shortage list
Serious Side Effects (Rare) Both medications carry small risks of serious complications including pancreatitis, gallbladder problems, kidney issues (usually from dehydration due to vomiting/diarrhea), and thyroid tumors (seen in animal studies but not confirmed in humans)
COA / Lab results Evidence: Preclinical Pros Studied for tendon, ligament, muscle and bone repair Angiogenic and gut-protective action in animal models Stable in gastric juice, unlike many growth-factor peptides Commonly paired with TB-500 in recovery protocols Cons Evidence is preclinical animal/in-vitro only, no human trials Human efficacy and dosing unestablished Pros and cons summarise available published data from peer-reviewed studies
